Research programme: anti-Ebola monoclonal antibodies - PlantForm Corporation

Drug Profile

Research programme: anti-Ebola monoclonal antibodies - PlantForm Corporation

Alternative Names: Antibodies for Ebola virus (Sudan) - PlantForm Corporation

Latest Information Update: 23 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PlantForm Corporation
  • Developer PlantForm Corporation; United States Army Medical Research Institute of Infectious Diseases
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Ebola virus infections

Most Recent Events

  • 13 Dec 2016 The University of New Mexico partners with PlantForm Corporation on Filoviridae glycoprotein project
  • 11 Jun 2015 Preclinical trials in Ebola virus infections in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top